Beverly Farms, MA, United States of America

Ullrich S Schwertschlag


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2000-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Ullrich S. Schwertschlag: Pioneering Innovations in Biomedical Treatments

Introduction

Ullrich S. Schwertschlag, an innovative inventor based in Beverly Farms, MA, is recognized for his significant contributions to the field of biomedical treatments. With two patents to his name, Schwertschlag focuses on the therapeutic applications of Interleukin-11, particularly in treating a range of debilitating conditions.

Latest Patents

Schwertschlag's latest patents include groundbreaking methods for utilizing IL-11 for treating mucositis and inflammatory bowel diseases. The first patent introduces topical formulations of Interleukin-11 designed to address various disorders such as Crohn's disease, ulcerative colitis, and mucositis in its many forms, including oral, gastrointestinal, nasal, and proctitis. His second patent also targets inflammatory bowel diseases, offering similar formulations and methods for treating associated conditions like psoriasis, aphthous ulcers, and even ocular diseases such as conjunctivitis and retinitis. These patents highlight his innovative approach to addressing complex health issues through targeted biomedical solutions.

Career Highlights

Schwertschlag's career is marked by his affiliation with Genetics Institute, Inc., where he actively contributes to research and development in the field of biotechnology. His commitment to understanding and treating inflammatory conditions has positioned him as a valuable asset to his team and the broader medical community.

Collaborations

Throughout his career, Schwertschlag has collaborated with notable colleagues, including Nick W. Warne and Camille L. Bedrosian. These partnerships have fostered an environment of innovation and have facilitated the development of effective solutions to pressing medical challenges.

Conclusion

Ullrich S. Schwertschlag's contributions to the field of biomedical treatment through his patents on Interleukin-11 underscore his role as an influential inventor. His work not only serves to enhance treatment options for those suffering from various diseases but also exemplifies the spirit of innovation within the medical research community. With ongoing efforts and collaborations, Schwertschlag continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…